MedPath

Fortuderm Ltd.

Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

Evaluation of DD-25 Topical Cream for the Treatment of Psoriasis Vulgaris : Proof of Concept Study

Phase 1
Conditions
Psoriasis Vulgaris
Interventions
First Posted Date
2012-10-08
Last Posted Date
2012-10-08
Lead Sponsor
Fortuderm Ltd.
Target Recruit Count
30
Registration Number
NCT01702324
Locations
🇮🇱

Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.